According to a newly published market research report by 24LifeSciences, global TIL cell therapy market was valued at USD 100 million in 2025 and is projected to reach USD 1,116 million by 2034, growing at a compound annual growth rate (CAGR) of 43.3% during the forecast period 2026-2034. Tumor-Infiltrating Lymphocyte (TIL) therapy represents a breakthrough in adoptive cell therapy for advanced...